🇦🇪 ENJAYMO in United Arab Emirates

ENJAYMO (SUTIMLIMAB-JOME) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

ENJAYMO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Arab Emirates

Frequently asked questions

Is ENJAYMO approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for ENJAYMO in United Arab Emirates?

RECORDATI RARE DISEASES, INC. is the originator. The local marketing authorisation holder may differ — check the official source linked above.